Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Global Parkinsons Disease Drugs Market Outlook 2022
Format : 
Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jan, 2018| No. of Pages : 100
Please make your selection :
Electronic Access - Single User License
US$ 2000.00
CD-ROM Mail Delivery
US$ 2200.00
Hard Copy Mail Delivery
US$ 2200.00
Electronic Access - Multi-User License
US$ 2800.00
List of Figures:
Figure 4-1: Global - Population 60 Years or Above (Billion), 2015, 2030 & 2050
Figure 5-1: Global - Parkinson’s Disease Drugs Market (Billion US$), 2016 & 2022
Figure 6-1: Global - Sales of Duodopa/Duopa (Billion US$), 2015 & 2016
Figure 6-2: Global - Sales of Azilect (Billion US$), 2015 & 2016
Figure 6-3: Global - Sales of Mirapex/Mirapex ER (Billion US$), 2015 & 2016
Figure 6-4: Global - Sales of Requip (Billion US$), 2015 & 2016
Figure 6-5: Global - Sales of Neupro (Billion US$), 2015 & 2016
Figure 6-6: Global - Sales of Rytary/Numient (Billion US$), 2015 & 2016
Figure 7-1: Global - Parkinson’s Disease Drugs Market by Type of Therapy (%), 2016
Figure 7-2: Global - Levodopa Therapy Market for Parkinson’s Disease (Billion US$), 2016 & 2022
Figure 7-3: Global - Dopamine Agonist Therapy Market for Parkinson’s Disease (Billion US$), 2016 & 2022
Figure 7-4: Global - MAO-B Inhibitor Therapy Market for Parkinson’s Disease (Billion US$), 2016 & 2022
Figure 7-5: Global - COMT Inhibitor Therapy Market for Parkinson’s Disease (Billion US$), 2016 & 2022
Figure 7-6: Global - Other Therapy Market for Parkinson’s Disease (Billion US$), 2016 & 2022
Figure 8-1: Global - Parkinson’s Disease Drugs Market by Geography (%), 2016
Figure 8-2: North America - Parkinson’s Disease Drugs Market (Billion US$), 2016 & 2022
Figure 8-3: North America - Population 60 Years or Above (Million), 2015, 2030 & 2050
Figure 8-4: Europe - Parkinson’s Disease Drugs Market (Billion US$), 2016 & 2022
Figure 8-5: Asia-Pacific - Parkinson’s Disease Drugs Market (Billion US$), 2016 & 2022
Figure 12-1: Abbvie Inc. - Breakup of Revenue by Geography (%), 2016
Figure 12-2: Boehringer Ingelheim International GmbH - Breakup of Sales by Business Segment (%), 2016
Figure 12-3: Boehringer Ingelheim International GmbH - Breakup of Sales by Geography (%), 2016
Figure 12-4: Teva Pharmaceutical Industries Limited - Breakup of Revenue by Business Segment (%), 2016
Figure 12-5: Teva Pharmaceutical Industries Limited - Breakup of Revenue by Geography (%), 2016
Figure 12-6: GlaxoSmithKline plc - Breakup of Group Turnover by Business Segment (%), 2016
Figure 12-7: GlaxoSmithKline plc - Breakup of Group Turnover by Geography (%), 2016
Figure 12-8: UCB S.A. - Breakup of Revenue by Geography (%), 2016
Figure 12-9: Novartis AG - Breakup of Sales by Business Segment (%), 2016
Figure 12-10: Novartis AG - Breakup of Pharmaceuticals Division Sales by Segment (%), 2016
Figure 12-11: Novartis AG - Breakup of Sales by Geography (%), 2016
Figure 12-12: Impax Laboratories, Inc. - Breakup of Revenue by Business Segment (%), 2016
Figure 12-13: Valeant Pharmaceuticals International, Inc. - Breakup of Revenue by Business Segment (%), 2016
Figure 12-14: Valeant Pharmaceuticals International, Inc. - Breakup of Revenue by Geography (%), 2016
Figure 12-15: Merck & Co., Inc. - Sales by Business Segments (%), 2016
Figure 12-16: Merck & Co., Inc. - Sales by Geography (%), 2016
Figure 12-17: Mylan N.V. - Breakup of Revenue by Geography (%), 2016
Figure 12-18: F. Hoffmann-La Roche Ltd. - Breakup of Sales by Business Segment (%), 2016
List of Tables:
Table 10-1: Mergers, Acquisitions & Collaborations in Parkinson’s Disease Drugs Market (2015-2017)
Table 11-1: Global - Drugs Pipeline of Parkinson’s Disease
Table 12-1: Abbvie Inc. - Key Financials (Billion US$), 2014-2016
Table 12-2: Abbvie Inc. - Marketed Parkinson’s Disease Products
Table 12-3: Abbvie Inc. - Parkinson’s Disease Products in Pipeline
Table 12-4: Newron Pharmaceuticals SpA - Key Financials (Million US$), 2014-2016
Table 12-5: Newron Pharmaceuticals SpA - Marketed Parkinson’s Disease Products
Table 12-6: Newron Pharmaceuticals SpA - Parkinson’s Disease Products in Pipeline
Table 12-7: Acadia Pharmaceuticals Inc. - Key Financials (Million US$), 2014-2016
Table 12-8: Acadia Pharmaceuticals Inc. - Marketed Parkinson’s Disease Products
Table 12-9: Boehringer Ingelheim International GmbH - Key Financials (Billion US$), 2014-2016
Table 12-10: Boehringer Ingelheim International GmbH - Marketed Parkinson’s Disease Products
Table 12-11: Teva Pharmaceutical Industries Limited - Key Financials (Billion US$), 2014-2016
Table 12-12: Teva Pharmaceutical Industries Limited - Marketed Parkinson’s Disease Products
Table 12-13: GlaxoSmithKline plc - Key Financials (Billion US$), 2014-2016
Table 12-14: GlaxoSmithKline plc - Marketed Parkinson’s Disease Products
Table 12-15: UCB S.A. - Key Financials (Billion US$), 2014-2016
Table 12-16: UCB S.A. - Marketed Parkinson’s Disease Products
Table 12-17: UCB S.A. - Parkinson’s Disease Products in Pipeline
Table 12-18: Novartis AG - Key Financials (Billion US$), 2014-2016
Table 12-19: Novartis AG - Marketed Parkinson’s Disease Products
Table 12-20: Impax Laboratories, Inc. - Key Financials (Million US$), 2014-2016
Table 12-21: Impax Laboratories, Inc. - Marketed Parkinson’s Disease Products
Table 12-22: Impax Laboratories, Inc. - Parkinson’s Disease Products in Pipeline
Table 12-23: Valeant Pharmaceuticals International, Inc. - Key Financials (Billion US$), 2014-2016
Table 12-24: Valeant Pharmaceuticals International, Inc. - Marketed Parkinson’s Disease Products
Table 12-25: Merck & Co., Inc. - Key Financials (Million US$), 2014-2016
Table 12-26: Merck & Co., Inc. - Marketed Parkinson’s Disease Products
Table 12-27: Mylan N.V. - Key Financials (Billion US$), 2014-2016
Table 12-28: Mylan N.V. - Marketed Parkinson’s Disease Products
Table 12-29: F. Hoffmann-La Roche Ltd. - Key Financials (Billion US$), 2014-2016
Table 12-30: F. Hoffmann-La Roche Ltd. - Marketed Parkinson’s Disease Products
Table 12-31: F. Hoffmann-La Roche Ltd. - Parkinson’s Disease Products in Pipeline
Table 12-32: US WorldMeds, LLC - Marketed Parkinson’s Disease Products
Table 12-33: US WorldMeds, LLC - Parkinson’s Disease Products in Pipeline
Not able to find data you are looking for? Ask our Research Analyst.
media citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2018, RNCOS, 2002-2018
About Us
Terms & Policy
Contact